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Abnormal hemodynamics and elevated angiotensin II plasma levels in
polydipsic patients on regular hemodialysis treatment. To investigate the
cause and the mechanisms responsible of the compulsive thirst and
excessive fluid intake observed in many patients on chronic dialysis
treatment, we measured plasma antidiuretic hormone (ADH), angioten-
sin II (Ang II) and some hemodynamic parameters in seven polydipsic
and in six normodipsic patients before hemodialysis, at the end of it and
several times during the interdialytic interval. Before dialysis we found
that ADH was elevated in both groups (6.9 1.9 vs. 6.9 1.3 pg/mI,
respectively in polydipsics and controls), whereas Ang II was abnor-
mally high only in polydipsics (51 12 vs. 11 3 pglml, P < 0.01);
these patients also had significantly higher heart rate and cardiac indices
and lower total peripheral resistances than control patients. Overall
these hemodynamic indices were related with Ang II but not with ADH.
Ang 11 rose markedly in polydipsics after dialysis, reaching a peak at the
fourth hour after its termination (136 12 pg/mI) and remained
consistently elevated throughout the interdialytic period, whereas in
controls Ang II was practically unchanged with respect to baseline. In
contrast, ADH had minor and similar modifications in both groups, in
whom also the hemodynamic changes were superimposable. Significant
correlations were found between the absolute and percent changes of
Ang II and those of plasma volume during the interdialytic interval (P <
0.001 for both), and between the individual values of Ang H measured
during the whole study and the interdialytic weight gain (P < 0.05).
These results demonstrate that polydipsic patients have abnormally
high levels of Ang II before and after the hemodialysis-induced volume
depletion. The high circulating levels of this peptide are expression of
the hyperreactivity of the renin system that, apparently, represents the
humoral counterpart of an hyperkinetic circulation which, in conjunc-
tion with the dipsogenic effect of Ang II, may be the cause of the
compulsive thirst complained by these patients.
Many patients on regular dialysis treatment (RDT) complain
of compulsive thirst which causes an exaggerated ingestion of
fluids. This in turn may lead to chronic fluid overload, extra-
cellular volume expansion and congestive cardiomyopathy with
risk of pulmonary edema [1]. Moreover, the need of a rapid
removal of the excess fluid by hemodialysis may expose these
patients to severe dialysis intolerance (nausea, headache,
cramps) and to dangerous fluctuations in blood pressure [2].
The cause of this polydipsia in RDT patients is still unclear.
Abnormally high plasma values of dipsogenic hormones [3—5]
such as antidiuretic hormone (ADH) and angiotensin II (Ang II)
have been found in several studies [5—10], however, to our
knowledge no attempts have been made to clarify the mecha-
nisms underlying these humoral alterations. To address this
question we evaluated plasma ADH, Ang II, osmolality and the
hemodynamic status in a group of polydipsic patients and in a
matched group of patients not suffering of compulsive thirst, the
measurement of these parameters being carried out before and
after dialysis and several times throughout the interdialytic
period.
Methods
Patients
Among the 85 patients who regularly attend our unit for RDT
we selected thirteen nephric, anuric patients for participating in
this study after informed consent. Seven of the thirteen, defined
as polydipsic, were selected because their interdialytic weight
gain expressed as percent of total body water (TBW) [11], was
in the upper tertile of those observed in the whole population of
our RDT patients (Fig. 1), whereas that of the remaining six
patients, serving as controls, was consistently in the lower and
intermediate tertiles. Except for this, patients of the two groups
had similar features including the dimensions of the artero-
venous fistulas which were always distally located in the
forearm. Their demographic and clinical features are reported
in Table 1. Polydipsic patients had slightly higher dry body
weight and body mass index (BMI 23.6 1.6 vs. 19.1 0.7, P
<0.05), these differences being essentially due to one moder-
ately obese subject (B.S.) whose BMI was 30.7. None of the
patients had diabetes, cardiac failure, active infections or other
associated diseases. In addition they were not on treatment
with antihypertensive agents, namely beta-blocking agents or
angiotensin converting enzyme (ACE) inhibitors which may
affect the activity of the renin system.
Protocol
All studies were performed after the "long" interdialytic
period that is, 72 hours after the end of the previous dialysis, in
the morning and in the fasting state. After patients had been
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Fig. 1. Frequency distribution curve of the percent changes in total
body water (TBW), according to Watson [11] in patients on RDT in our
unit (N = 85). Data refer to the mean of the individual increments in
TBW observed in the long interdialytic period during the six months
preceding the study. Patients were then stratified by 1% intervals of
TBW. Note that all polydipsic patients (Table 1) consistently had TBW
increments during the long interval in the upper tertile of the curve,
whereas those of control patients were consistently in the lower-
intermediate tertiles.
weighed they were asked to maintain the supine position, and
the arterial and venous lines were connected to the brachial
fistula and a bioimpedance device (Bomed NCCOM 3 Medical
Manufactoring, Irvine, California, USA) was applied to the
thorax for hemodynamic measurements. This device consists of
two pairs of electrodes, one placed (recording electrodes) at the
root of the neck and at the level of the xiphisternum and the
other (injecting electrodes) 5cm above and below the recording
electrodes. A constant current sinusoidal field generator was
connected to the injecting electrodes, the impulses of which are
triggered by the R wave of a precordial electrocardiograph lead.
The accuracy of this impedenziometric method for the measure-
ment of cardiac output (CO) in RDT patients in resting condi-
tions has been confirmed by previous reports [12, 13] and by our
own studies [141. Finally, a mercury sphygmomanometer was
applied on the contralateral arm to the arterio-venous fistula for
blood pressure measurements. Thirty minutes after the comple-
tion of these maneuvers 20 ml of blood were collected for the
determinations of plasma ADH, Ang II, total protein (TP), total
osmolality, sodium (Na) and micro-hematocrit, and a se-
quence of at least three measurements of CO, heart rate (HR)
and blood pressure were recorded. Afterwards all patients
underwent a four hour hemodialysis performed with a 1.2 m2
cuprophan hollow-fiber dialyzer. The dialysate contained 138
Na, 3.0K, 110 Cl—, 31 NaHCO3, 5.OmEq/literCH3COONa,
2.0 Ca and 0.75 mrnol/liter Mg with the theoretical osmolar-
ity of 290.25 mOsm/liter. During dialysis blood pressure was
checked at 60 minute intervals to detect possible hypotensive
episodes. At the end of the session after each reached his or her
dry body weight, as defined by Maher [15], patients were
weighed again and the hemodynamic and humoral determina-
tions repeated as prior to dialysis. Patients remained in our unit
for the following four hours, and then they were sent home to
return eight, 24 and 48 hours after the end of dialysis. At these
times they were reinvestigated as above except that the blood
samples were collected from a peripheral vein. Throughout this
time patients were allowed to eat and to drink according to their
usual dietary habits.
Methods
Cardiac output was measured by the impedenziometric
method described above, its variability being 8%. Total periph-
eral resistances (TPR) were calculated using the formula TPR =
(MAP/CO) x 80, where MAP is the mean arterial pressure
(diastolic pressure plus 1/3 of pulse pressure); CI (liter/min/m2)
and TPRI (dyne/sec/cm5/m2) were calculated dividing CO and
TPR by body surface area expressed in m2. Heart rate was
derived from the ECG tracings.
Blood for ADH and Ang II measurements was collected in
pre-chilled plastic tubes containing 200 pA of 10% solution of
Na2 ethilendiamine tetracetic acid (EDTA) as anticoagulant and
to prevent the degradation of the peptides; in those for Ang II
300 pA of 0.5% solution of phenanthroline (Sigma Chemical Co.,
St. Louis, Missouri, USA) were also added for further protec-
tion. Both peptides were measured by conventional radioimmu-
noassay after extraction from plasma with minicolumns of
Amberlite CG5O resin (ADH) and C18 Sep-Pak Cartridges (Ang
II). The details of these procedures have been described else-
where [16, 17]. In short, the recovery of both peptides after
extraction was in the range of 90%, the sensitivity of the assay
was 0.3 and 1.25 pg/tube, respectively for ADH and Ang II, and
their interassay variabilities were 10% and 16%. In our lab the
range of normal values was 1 to 3 pg/mI for ADH and 5 to 25
pg/mi for Ang II.
Total plasma osmolality was evaluated using the freezing
point depression method (Fiske Osmometer, Fiske Associates,
Needam Heights, Massachusetts, USA). Total protein and Na
concentration were automatically determined using a Monarch
2000 Autoanalyzer (Instrumentations Lab., Lexington, Massa-
chusetts, USA) whereas the changes in plasma volume (PV)
throughout the interdialytic period with respect to baseline
conditions were indirectly evaluated from the changes in TP
using the formula:
(I — TP predial.)PV=— xlOO[18JTP postdial.
Statistics
Results are expressed as means The statistical signif-
icance of the changes observed during the interdialytic period
with respect to baseline was first assessed within groups with
the analysis of variance (ANOVA) for repeated measures
followed by the Neumann-Keuls test for selected comparisons
between baseline values and those observed at the various time
after dialysis; time-matched data between groups were then
compared with Student's i-test. Linear regression analysis was
used to determine the correlation between two variables, the
correlation coefficient being calculated using the Pearson's test.
A value of P < 0.05 was taken as the level of statistical
significance.
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Table 1. Demographic and clinical data of patients enrolled in the study
Age DA
DBW
Interdialytic weight gains
Mean of previous 6 months Dun ng study Interdialytic
weight decrements
during study% %
Name Sex Diagn years kg kg Range TBW Range kg TBW kg
Control patients (N = 6)
C.R. M CPN 57 8 58.0 2.2 1.9—2.4 6.5 5.6—7.1 2.0 5.9 2.4
V.B. F CGN 61 9 39.0 1.8 1.5—2.1 7.9 6.6—9.2 1.2 5.3 2.0
T.A. M CON 64 8 44.2 1.4 1.2—1.6 5.4 4.7—6.2 1.0 3.9 1.9
P.O. M CON 46 14 56.0 2.6 2.4—2.8 8.0 7.3—8.6 2.4 7.3 2.8
F.I. M CGN 58 19 48.2 2.4 2.3—2.5 8.6 8.3—9.0 1.8 6.4 2.5
A.F. M CPN 55 13 55.3 1.7 1.5—1.9 5.3 4.7—5.9 2.0 6.2 1.9
Mean SEM 56.8
2.5
11.8 50.1
3.1
2.0
0.2
6.9
0.6
1.7 5.8 2.3
Polydipsic patients (N = 7)
S.V. F HUS 36 11 65.5 4.2 3.8—4.4 11.0 10.0—11.5 3.0 7.8 3.7
P.G. F CPN 46 16 54.5 4.1 3.8—4.4 13.0 12.0—13.9 3.6 11.3 3.9
B.S. M CPN 47 8 86.5 5.1 4.8—5.2 10.3 9.6—10.4 4.3 8.6 3.9
S.P. M CON 58 8 45.5 3.7 3.5—4.0 14.0 13.3—15.1 2.6 9.8 3,5
M.C. F CPN 50 7 75.5 4.5 4.2—4.8 10.3 9.6—10.9 2.9 6.6 3.6
M.R. M CON 48 10 55.0 4.3 4.2—4.4 13.4 13.1—13.7 4.5 14.0 4.0
Z.M. F CPN 57 19 61.5 3.9 3.8—4.1 10.9 10.6—11.5 2.8 7.8 3.5
Mean SEM 48.8 9.8
2.8 1.1
63.4
5.3
4.2
0.2
11.9
0.6
3.4
0.3
9.4
1.0
3.7
0.1
P< NS NS NS 0.001 0.01 0.01 0.01 0.01
Abbreviations are: CPN, chronic pyelonephritis; CON, chronic glomerulonephritis; HUS, hemolytic uremic syndrome; DA, dialytic age; DBW,
dry body weight [15]; %TBW, percent of total body water (calculated according to Watson) [11]. The mean as well as the range of the interdialytic
weight gains of the previous six months refer, as in Fig. I, to those observed after the long interval and, for this reason, are substantially greater
than those of the study which were observed during the short interval. For the same reason these latter are, in general, smaller than the
corresponding intradialytic weight decrements.
Table 2. Baseline hemodynamic and humoral data of patients enrolled in the study
Na TPRI Ang H ADH
Tot.osm mEq/ MAP HR CI dyne/sect
Name Hct % mOsm/kg liter mm Hg beats/mm liter/minim2 cm5/m2 pg/mi
Control patients (N = 6)
C.R. 35 329 141 93 71 3.9 697 18.6 5.8
yB. 40 339 136 90 67 3.8 1352 27.4 2.5
TA. 28 320 141 103 67 2.4 1678 10.4 12.5
P.O. 36 316 142 106 52 3.0 1037 11.1 4.7
F.I. 25 310 141 103 60 2.7 1503 11.3 6.4
A.F. 32 297 144 103 47 2.5 1288 7.3 9.8
Mean SEM 32 2.0 318 6.0 141 1 99 2 61 4 3.0 0.3 1259 143 11.3 2.7 6.9 1.3
Polydipsic patients (N = 7)
S.V. 27 322 143 70 98 4.8 400 44.8 6.9
P.G. 18 336 142 113 79 6.9 602 43.0 4.5
B.S. 30 328 136 96 91 4.5 464 123.0 7.3
S.P. 34 310 138 96 66 3.2 1286 37.5 3.0
M.C. 30 314 134 106 94 3.4 749 60.8 8.0
M.R. 32 291 140 107 92 4.3 812 18.1 4.4
Z.M. 26 340 140 93 70 5.2 556 29.7 14.4
Mean SEM 28 1.8 320 6.4 139 1 97 5 84 5 4.5 0.5 696 113 51.0 13.0 6.9 1.9
P< NS NS NS NS 0.01 0.05 0.01 0.01 NS
Abbreviations: Hct, hematocrit; Tot.osm, plasma total osmolality. Other abbreviations are in the text.
Results and lower mean levels of TPRI than control patients. Also,
hematocrit was slightly but not significantly lower in polydip-
Basal data sics, whereas MAP, TP, total osmolality and Na concentra-
The individual basal values of some of the hemodynamic and tions (Tables 2 and 3) were similar in the two groups. Plasma
humoral parameters investigated are reported in Table 2. Poly- ADH was also similar and above the upper normal limits in all
dipsic patients had significantly higher mean levels of HR, CI but two cases (one polydipsic, one control). In contrast, plasma
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Table 3. Biochemical data at baseline and their variations throughout the study in polydipsic (P) and control (C) patients
Before HD End HD 4 hours 8 hours 24 hours 48 hours p<a
Body wt P
C
—
—
—3.7 0.1
—2.3 0.1
—3.2 0.1
—1.9 0.1
—2.9 0.1
—1.8 0.1
—1.9 0.1
—1.1 0.1
—0.3 0.1
—0.5 0.1
0.001
0.001
p<b 0.001 0.005 0.001 NS NS
TP P 6.8 0.1 9.3 0.3 8.4 0.3 7.9 0.3 7.6 0.2 7.0 0.1 0.001
C 6.7 0.3 7.9 0.4 7.5 0.4 7.6 0.4 7.3 0.4 7.0 0.4 0.01
p<b NS 0.01 NS NS NS NS
PV P — —26.5 2.5 —18.4 2.2 —13.1 2.7 —9.1 2.2 —1.7 2.4 0.001
C — —15.8 3.5 —11.6 2.6 —10.5 2.7 —7.3 1.6 —5.0 2.3 0.01
P<" 0.05 NS NS NS NS
Tot. osm P 320 6.4 288 4.1 300 3.1 298 2.9 302 4.2 307 3.9 0.01
C 318 6.0 300 2.8 307 4.3 305 3.2 305 4.8 375 6.0 NS
p<b NS NS NS NS NS NS
Abbreviations are in Tables 1 and 2 and in the text. HD is hemodialysis and the hours refer to the time intervals after its completion. The data
of body weight (body wt) refer to the absolute decrements in kg, whereas those of plasma volume (PV) refer to the calculated percent changes of
this parameter with respect to baseline values.
a Overall significance of the changes within each group (ANOVA)b Significance of the differences between groups at each time of the study
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Apg II was abnormally high in six of the seven polydipsic
patients but only in one out of the six controls. Overall plasma
Ang II was positively correlated with HR (r = 0.62) and
inversely with TPRI (r =
—0.58, P < 0.05 for both) whereas the
correlation with CI failed to reach statistical significance (r =
0.39, Fig. 2). No such correlations were found for ADH. No
correlations were found between ADH and Ang II and total
osmolality. Finally, a significant correlation was found between
CI and the interdialytic weight gain prior to study (r =0.61, P
<0.05).
Effects of hemodialysis
Hemodialysis caused a marked and significant decrease in
body weight and TBW, and increased TP indicating a significant
reduction in PV (Table 3). These changes peaked at the end of
hemodialysis and were more pronounced in polydipsic patients
as indicated as by the finding that their hematocrits were similar
to those of normodipsic patients at that time (35.6 3.1 vs. 35.8
3.0). Thereafter all these parameters progressively returned
toward baseline values, the differences between the two groups
no longer being statistically significant. These changes were
associated with specular increments in HR and CI and with
decrements in TPRI, the magnitude of which was similar in the
two groups throughout the study (Table 4). However, because
of the differences in baseline values, HR, CI and TPRI re-
mained significantly different in the two groups during the
whole period of observation. Overall the changes in PV were
inversely correlated with those in HR (r =
—0.33, P < 0.01) but
not with those in CI and TPRI. Also, no correlations were found
between the changes in CI and those in PV, body weight and
Ang II during the postdialytic period. Mean arterial pressure
decreased to a similar extent in the two groups only at the end
of dialysis; its values thereafter were not significantly different
from those found prior to dialysis. Total osmolality decreased in
both groups and slightly more so in polydipsic patients (Table
3), whereas Na concentration remained unchanged.
In polydipsic patients Ang II rose almost threefold by the
fourth hour after dialysis and declined thereafter toward basal
values, whereas it was practically unchanged throughout the
study in control patients (Fig. 3). Overall the absolute and
percent changes in Ang II were correlated with those in PV (r =
0.50 and 0.55, P < 0.001 for both; Fig. 4). In addition, the
individual area under the curve (AUC) of Ang II, calculated by
the trapezoidal rule [19] as the integrated area of the absolute
values of Ang II measured throughout the study, was signifi-
cantly correlated (r = 0.53, P < 0.05) with the interdialytic
weight gain (Fig. 5).
Plasma ADH had a much less uniform pattern of response
(Fig. 3) in that it increased to a similar extent after dialysis in
both groups, the increments being, however, not significant and
B
C
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4050 60 70 80 90100
HR, beats/mm
2 4 6 8 400 800 1200 1600 2000
TPRI dyne/sec/cnr5/m2CI liter/mm/rn2
Fig. 2. Relationship between baseline Ang II
levels and HR, CI and TPRI (A, B, and C,
respectively) in controls (0, N 6) and in
polydipsic patients (•, N = 7).
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Table 4. Hemodynamic data at baseline and throughout the study in polydipsic (P) and control patients (C)
Before HD knd HD 4 hours 8 hours 24 hours 48 hours P<
MAP P 97±5 86±6 91±6 96±6 99±7 100±5 NS
,nmHg C 99±2 83±6 98±8 98±9 95±3 100±5 NSP< NS NS NS NS NS NS
HR P 84±5 98±7 91±7 92±7 86±7 81±4 0.01
beats/mm C 61 4 71 6 64 3 70 3 65 4 62 4 0.01
P< 0.01 0.05 0.01 0.05 0.05 0.01
CI P 4.6 0.5 4.8 0.6 4.9 0.6 5.1 0.6 5.3 0.6 4.8 0.6 NS
liter/min/,n2 C 3.0 0.3 3.3 0.2 3.4 0.6 3.7 0.3 3.3 0.3 3.1 0.4 NS
P< 0.05 NS NS 0.05 0.05 0.05
TPRI P 696 113 578 72 574 64 594 95 607 91 635 103 NS
dyne/sec/cm 51m2 C 1259 143 916 63 1092 125 977 115 1110 168 1267 169 0.05
P< 0.01 0.01 0.01 0.05 0.05 0.01
Abbreviations are in the preceding tables and in the text.
C
I
Fig. 3. Values of plasma Ang II (A) and ADH (B) during the study in
control patients (D, N = 6) and in polydipsic patients (0, N = 7). HD
indicates hemodialysis. The asterisks indicate the statistical significance
(P < 0.05 at least) of the changes in Ang II with respect to baseline
values in polydipsic patients.
were confined to the end of the session and at eight hours
afterwards. No correlation was found between the changes in
ADH and those in Ang II, PV, any of the hemodynamic
parameters, osmolality and the interdialytic weight gain.
Discussion
In patients with chronic renal failure the drinking behavior
may be disturbed by a number of metabolic, humoral and
psychological factors [1]. Moreover, in some of them when on
RDT, the sensation of thirst is further exacerbated by the
periodical subtraction of body fluids leading to reactive hyper-
dipsia and excessive weight gain during the intervals between
dialysis. In agreement with previous studies [9, 10], in our
patients we found abnormally high levels of ADH both before
dialysis and during the interdialytic period. Most likely this
elevation of ADH depends upon the augmented secretion of the
peptide in response to the disturbances of osmoregulation
combined with the reduction of its renal catabolism [20—22].
ADH tended to augment at the end of hemodialysis probably as
a consequence of the increase in peptide secretion and of the
contraction of plasma volume partly counterbalanced by filtra-
tion of the peptide through the highly permeable membranes of
the dialyzer [23, 24]. The multifactorial origin of the modifica-
tions in ADH after dialysis is further supported by the lack of
correlation with all the humoral and hemodynamic variables
investigated herein. Yet, whatever is the mechanism(s) respon-
sible for these changes, it is unlikely that ADH is the cause of
the interdialytic hyperdispsia because its levels were always
similar in polydipsic and control patients. Rather, our findings
indirectly confirm what others have inferred from animal exper-
iments [25] and from observations in humans [26], that is, that
the anatomical pathways subserving thirst and ADH secretion,
whatever the facilitatory mechanism may be, are likely to be
anatomically distinct.
In contrast to ADH we found that, prior to dialysis, Ang II
was abnormally high almost exclusively in polydipsic patients.
This observation, which is in agreement with that of others
[6—81, might be unexpected because before dialysis the activity
of the renin system should be maximally suppressed by the
expansion of plasma and extracellular volume. The elevation in
Ang II found in polydipsics cannot even be attributed to
differences in blood pressure and plasma Na concentrations,
two factors known to control renin secretion [27], because the
mean levels of these two variables were similar in the two
groups. Rather, the higher values of baseline heart rate found in
polydipsics as well as the overall positive correlation between
this parameter and Ang II suggest that in these patients the
tonic activity of the renin system is under the control of an
increased sympathetic drive which counteracts the peripheral
vasodilatation. This hypothesis is supported by the finding that
cardiac index was higher and total peripheral resistances were
lower in polydipsics than in control patients. Moreover, both
heart rate and total peripheral resistances were, at baseline,
correlated with Ang II as if polydipsics were subjects with a
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peptide may have further stimulated heart rate and cardiac
index via a positive feedback mechanism because Ang II is
known to have vagolytic properties and to augment cardiac
contractility [28, 29]. It is unlikely that the cardiotonic effect of
Ang II was the major determinant of high cardiac indices
because the relationship between these two parameters was
short of statistical significance at baseline and totally absent
during the remaining of the study.
The primary mechanism responsible for the hemodynamic
pattern observed in polydipsic patients is not clarified by our
study. The high cardiac indices could be due to volume over-
load as it is suggested by the significant relationship found
between these indices and the interdialytic weight gain prior to
study; a compensatory baroreflex-mediated reduction in sym-
pathetic activity might also justify the low total peripheral
resistences. Yet, this explanation is difficult to reconcile with
the high levels of Ang II and of heart rate which are both
expressions of increased rather than decreased sympathetic
activity. In addition, no relationship was found between the
changes in plasma volume or in weight gain and cardiac indices
during the post-dialytic period; this again denies the possibility
that volume overload is the cause of the greater cardiac indices
found in polydipsics throughout the study. Severe anemia can
cause an hyperkinetic circulation, but this does not appear to be
the case because hematocrits of polydipsics were only slightly
lower than those found in control patients before hemodialysis
and similar at the end of it, suggesting that the modest differ-
ence observed in baseline condition is largely accounted for by
the arguable greater expansion of plasma volume. An alterna-
tive possibility is that polydipsics are particularly sensitive to
> —40 r=0.50
•
—80
+10
40
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00•0
• S..
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••
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r=0.55
.
Fig. 4. Relationship between the individual
absolute and percent changes in plasma Ang
ii after hemodialysis and the percent changes
in plasma volume (PV) (N = 65, P < 0.001
for both). Symbols are: (0) controls, N 30;(•) polydipsics, N = 35.
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Fig. 5. Relationship between the interdialytic weight gain and the
individual overall values of Ang I! expressed as the area under the
curve (A UC) as described in the text [19]. Symbols are: (0) controls, N
= 6; (5) polydipsics, N = 7.
hyperkinetic circulation, the humoral counterpart of which is
represented by an hyperactive renin system. Since in these
patients the high Ang II levels coexist with low-normal systemic
blood pressures we cannot exclude that the excess of the
r=0.53
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the formation of endotoxins related to the blood/cuprophane
membrane interaction which is known to cause complement
and neutrophils activation and, as a consequence, the synthesis
of vasodilatatory substances such as cytokines [30, 311.
In polydipsic patients we also found that Ang II rose mark-
edly after dialysis and remained elevated during the interdia-
lytic interval in spite of the progressive re-expansion of plasma
volume. These increments of Ang II cannot be explained by the
same combination of mechanisms proposed for ADH because
they did not occur in control patients in whom the changes in
plasma volume, except at the very end of hemodialysis (Table
3), were only slightly smaller than in polydipsics. Thus the
greater response ofAng II observed in these patients during the
postdialytic period cannot be attributed to a greater volume
depletion. Moreover, we found a highly significant inverse
correlation between the absolute and percent changes in Ang II
after dialysis and those in plasma volume (Fig. 4). Therefore,
even if plasma renin activity was not measured in this study, it
appears that the increases of Ang II resulted from a real, further
activation of the renin system in response to volume depletion
and also that polydipsic patients are hyperreactive to this
stimulus. These findings go along with those observed prior to
dialysis and support the notion that even during the interdialytic
interval, despite the greater and faster volume re-expansion, the
augmented activity and reactivity of the renin system of poly-
dipsic patients is aimed at counterbalancing the peripheral
vasodilatation and at supporting blood pressure. Indeed,
throughout the study mean blood pressure of these subjects was
consistently similar to that of control patients in spite of much
higher levels of Ang II.
The negative counterpart of this hemodynamic pattern is that
unloading of cardiovascular baroreceptors associated with va-
sodilatation and hemodialysis induced volume depletion can be
a stimulus of extracellular thirst per se [32] which can be further
enhanced by the potential dipsogenic effect of Ang II. Acute
studies in humans have shown that when Ang II is infused
intravenously, the plasma concentration needed for inducing
thirst and increased water intake is in the range of 400 to 500
pg/ml, that is, almost double of that found in our patients at the
peak of the response to hemodialysis [26, 33]. However, others
have set the dipsogenic threshold of circulating Ang II at lower
levels [34]. Also, the elevation of endogenous Ang II generated
in response to reduction in plasma volume may have different
effects on thirst than exogenous Ang II. This is supported by the
finding that the drinking response to water deprivation which
usually attains Ang II levels much lower than that obtained with
i.v. infusion [35], is significantly reduced by ACE inhibitors
[36]. Moreover, it should be kept in mind that in our patients the
dipsogenic effect of endogenous Ang II has probably been
facilitated by the lack of elevation in blood pressure that one
would normally expect in response to these high levels of the
peptide. Indeed, it has been shown in animals that the dipso-
genic effect of Ang II was greatly enhanced when the pressor
response to the infused peptide was prevented by pretreatment
with either ACE inhibitors or aspecific vasodilating agents [37].
Finally, the positive correlation found between the individual
overall values of Ang II and the interdialytic weight gain (Fig. 5)
lend support to the idea that in this setting Ang II may
contribute, in conjunction with the baroreceptor mechanism, to
the thirst and to the consequent excess in water intake observed
in hyperdipsic patients.
Ang II may have exerted its dipsogenic effects by a number of
mechanisms. According to the classical Fitzsimons' view [3]
the peptide might enhance the sensitivity of the vascular stretch
receptors in the great veins and in low pressure atria of the heart
thus amplifying the effect of hypovolemia on the vagal and
sympathetic afferents which signal to the central nervous sys-
tem the need of reconstituting the extracellular fluid. Alterna-
tively, plasma Ang II may act directly on thirst-related angio-
tensin receptors of the circumventricular organs which, being
outside the blood-brain barrier, are accessible to the circulating
peptide [38]. This limitation may even not be true in our setting
because it has been shown that when Ang II levels are very high
or the blood-brain barrier less resistant, the peptide can pene-
trate the brain parenchima and act on receptor normally not
available [39]. Another possibility is that the levels of blood
borne Ang II reflect the activity of the brain renin-angiotensin
system which also has been shown to be involved in thirst
regulation [40, 41]. Finally, we cannot exclude that Ang II may
have potentiated the dipsogenic effects of other peptides such
as insulin [42].
An important practical implication of our study is that the
thirst and the excess water intake of polydipsic patients might
be alleviated by treating them with drugs which antagonize the
renin system. This has been done already with beneficial results
[8, 43]. Yet, if the increments in Ang II are important for blood
pressure maintenance, as it appears from our hemodynamic
data, then these compounds should be used with caution in
view of the possible hypotensive episodes that they may
precipitate during the dialysis [44].
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